Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Precision Medical Devices Market Size, Share, Trends, and Forecast, 2026-2036 | AI, Robotics, and Connected Care Drive a $98.4 Billion Opportunity at 6.2% CAGR

globenewswire.com
MDT Medtronic plc is listed as a leading company in the precision medical devices market, which is projected to grow significantly. The article highlights the company's role in a growing industry driven by AI, robotics, and connected care. GEHC GE HealthCare Technologies Inc. is identified as a key player in the growing precision medical devices market. The company's involvement in advanced imaging and AI-driven diagnostics positions it to benefit from market trends. ABT Abbott Laboratories is mentioned as a major medical device company contributing to the growth of the precision medical devices market. The company's focus on diagnostics and monitoring devices aligns with market drivers. BSX Boston Scientific Corporation is listed as a leading company in the precision medical devices market. The company's portfolio likely includes devices benefiting from trends in minimally invasive surgery and interventional procedures. ISRG Intuitive Surgical, Inc. is named as a leading company in the precision medical devices market. Its expertise in robotic surgical systems directly aligns with the article's emphasis on robotics driving market growth. JNJ Johnson & Johnson (MedTech) is listed as a leading company in the precision medical devices market. Its broad healthcare portfolio positions it to benefit from the overall growth and technological advancements in the sector. BDX Becton, Dickinson and Company (BD) is mentioned as a leading company in the precision medical devices market. Its role in diagnostics and medical supplies supports the overall growth trends discussed in the article. ZBH Zimmer Biomet Holdings is listed as a leading company in the precision medical devices market. Its focus on orthopedic implants positions it to benefit from the growth in this application area. RMD ResMed Inc. is mentioned as a leading company in the precision medical devices market. Its focus on respiratory care and connected monitoring devices aligns with the article's emphasis on telehealth and chronic disease management. MASI Masimo Corporation is listed as a leading company in the precision medical devices market. Its expertise in monitoring technologies, particularly in respiratory and pulse oximetry, aligns with the growth in monitoring devices.

Global Precision Medical Devices Market Size, Share, Trends, and Forecast, 2026-2036 | AI, Robotics, and Connected Care Drive a $98.4 Billion Opportunity at 6.2% CAGR Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Precision Medical Devices Market Size, Share & Trends Analysis - Global Opportunity Analysis & Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.

The global precision medical devices market is projected to grow from USD 53.7 billion in 2026 to USD 98.4 billion by 2036, registering a CAGR of 6.2% during the forecast period. According to the report, market expansion is being driven by the growing adoption of precision medicine and the integration of artificial intelligence, machine learning, robotics, advanced imaging, and sensor technologies into clinical device platforms.

Healthcare systems are increasingly shifting toward proactive, personalized care supported by high-resolution clinical data and advanced analytics. This transition is accelerating demand for AI-enabled diagnostic platforms, wearable sensors, remote patient monitoring systems, robotic-assisted surgery, image-guided interventions, and personalized implantable devices. Connected healthcare ecosystems are also enabling continuous monitoring across clinical and home healthcare settings, supporting improved diagnostic accuracy, treatment planning, and patient outcomes.

Market Segmentation

The precision medical devices market is segmented by device type, technology, application, end user, connectivity, and geography. Device categories include diagnostic devices, monitoring devices, therapeutic devices, surgical & interventional devices, and implantable devices. Technologies covered include artificial intelligence & machine learning, robotics & automation, sensor & biosensor technologies, imaging technologies, and 3D printing & additive manufacturing.

Key applications include cardiology, oncology, neurology, orthopedics, diabetes management, and respiratory care. Major end users include hospitals & clinics, Ambulatory Surgical Centers (ASCs), diagnostic laboratories, home healthcare settings, and research & academic institutes. Connectivity categories comprise standalone devices, connected / IoT-enabled devices, and cloud-integrated devices.

Device Type and Technology Outlook

Diagnostic devices are expected to account for the largest market share in 2026. Growth in this segment is supported by sustained investment in advanced imaging systems, molecular & genomic diagnostics, and point-of-care diagnostics for early disease detection and clinical decision-making.

Monitoring devices are projected to record the highest CAGR through 2036, led by continuous glucose monitors, cardiac monitors, wearable health devices, and remote patient monitoring platforms. The continued expansion of telehealth and decentralized chronic disease management is expected to strengthen demand for connected monitoring solutions.

Surgical & interventional devices are also positioned for strong growth as healthcare providers invest in robotic surgical systems, minimally invasive instruments, and image-guided surgical devices. These technologies support greater procedural accuracy, shorter recovery periods, and improved clinical efficiency.

Imaging technologies are expected to hold the largest technology share in 2026 due to their central role in precision diagnostics and personalized treatment planning. Artificial intelligence & machine learning are forecast to register the fastest growth as AI capabilities are incorporated into image interpretation, pathology detection, predictive analytics, and clinical decision support. Sensor & biosensor technologies will benefit from the continued miniaturization of home-based and wearable medical devices.

End User Trends

Hospitals & clinics are expected to remain the largest end-user segment in 2026, supported by their concentration of advanced diagnostic, surgical, and therapeutic infrastructure. Home healthcare settings are projected to achieve the highest CAGR as smartphone-connected devices, remote care platforms, and cloud-integrated monitoring systems become more widely adopted.

Ambulatory Surgical Centers are also increasing their use of precision medical devices to provide cost-effective, high-quality outpatient procedures. Diagnostic laboratories and research & academic institutes will continue to support market development through molecular testing, clinical research, and medical technology innovation.

Regional Market Analysis

North America is expected to command the largest share of the precision medical devices market in 2026. Regional growth is supported by substantial healthcare expenditure, advanced reimbursement structures, established regulatory pathways, and rapid clinical adoption of AI, robotic, and connected medical technologies. The presence of major medical device companies, including Medtronic, Abbott, and GE HealthCare, further reinforces the region's leadership.

Asia-Pacific is projected to be the fastest-growing regional market through 2036. Expanding healthcare infrastructure across China, India, and Southeast Asia, combined with a large aging population and rising chronic disease prevalence, is increasing demand for precision diagnostic and monitoring devices. Government healthcare modernization programs and growth in domestic medical device manufacturing are creating additional opportunities. Japan and South Korea remain prominent markets for imaging and robotic technologies.

Europe represents a significant market, supported by clinical research capabilities, advanced healthcare systems, and increasing adoption of connected health technologies and precision surgical tools. Germany, the U.K., and France are key regional markets, while EU MDR requirements continue to shape product development and commercialization strategies. Siemens Healthineers and Philips Healthcare are among the region's notable industry participants.

Latin America and the Middle East & Africa are emerging markets benefiting from healthcare infrastructure investment and rising demand for advanced diagnostic, monitoring, and robotic systems. Israel and the UAE are important demand centers in the Middle East & Africa, while Latin American growth is supported by efforts to address the increasing burden of non-communicable diseases.

Competitive Landscape

Leading companies operating in the global precision medical devices market include Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips Healthcare, Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, Intuitive Surgical, Inc., Johnson & Johnson (MedTech), Becton, Dickinson and Company (BD), Roche Diagnostics, Dexcom, Inc., Zimmer Biomet Holdings, ResMed Inc., and Masimo Corporation.

The report evaluates market revenue, historical performance, growth drivers, emerging opportunities, competitive positioning, and strategic developments. It also provides country-level analysis across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, identifying the device types, technologies, applications, end users, and connectivity models expected to generate the strongest commercial opportunities through 2036.

Key Topics Covered:

1. Introduction

1.1 Market Definition

1.2 Market Ecosystem

1.3 Currency and Limitations

1.3.1 Currency

1.3.2 Limitations

1.4 Key Stakeholders

2. Research Methodology

2.1 Research Approach

2.2 Data Collection & Validation Process

2.2.1 Secondary Research

2.2.2 Primary Research & Validation

2.2.2.1 Primary Interviews with Experts

2.2.2.2 Approaches for Country-/Region-Level Analysis

2.3 Market Estimation

2.3.1 Bottom-Up Approach

2.3.2 Top-Down Approach

2.3.3 Growth Forecast

2.4 Data Triangulation

2.5 Assumptions for the Study

3. Executive Summary

4. Market Overview

4.1 Introduction

4.2 Market Dynamics

4.2.1 Drivers

4.2.1.1 Growing Adoption of Precision Medicine and Personalized Healthcare

4.2.1.2 Increasing Demand for Minimally Invasive Procedures

4.2.1.3 Advancements in Imaging, Robotics, and Sensor Technologies

4.2.1.4 Rising Prevalence of Chronic Diseases

4.2.2 Restraints

4.2.2.1 High Cost of Advanced Precision Devices

4.2.2.2 Complex Regulatory Approval Processes

4.2.2.3 Integration Challenges with Healthcare IT Systems

4.2.3 Opportunities

4.2.3.1 Growth in Wearable and Remote Monitoring Devices

4.2.3.2 Expansion of AI-Enabled Diagnostic Devices

4.2.3.3 Increasing Adoption in Emerging Markets

4.2.3.4 Development of Personalized Implantable Devices

4.2.4 Challenges

4.2.4.1 Data Accuracy and Interoperability Issues

4.2.4.2 Cybersecurity Risks in Connected Devices

4.3 Technology Landscape

4.3.1 AI and Machine Learning in Medical Devices

4.3.2 Robotics and Computer-Assisted Surgery

4.3.3 Advanced Imaging Technologies

4.3.4 Biosensors and Wearable Technologies

4.3.5 3D Printing and Personalized Implants

4.4 Value Chain Analysis

4.4.1 Component Suppliers (Sensors, Chips, Materials)

4.4.2 Device Manufacturers

4.4.3 Software & AI Platform Providers

4.4.4 Healthcare Providers

4.4.5 Patients & End Users

4.5 Regulatory and Standards Landscape

4.5.1 FDA Medical Device Regulations

4.5.2 EU MDR and CE Marking

4.5.3 ISO Standards (ISO 13485, IEC 60601)

4.5.4 Data Privacy Regulations (HIPAA, GDPR)

4.6 Porter's Five Forces Analysis

5. Precision Medical Devices Market, by Device Type (Primary Segmentation)

5.1 Introduction

5.2 Diagnostic Devices

5.2.1 Imaging Systems (MRI, CT, Ultrasound)

5.2.2 Molecular & Genomic Diagnostic Devices

5.2.3 Point-of-Care Diagnostic Devices

5.3 Therapeutic Devices

5.3.1 Laser-Based Treatment Devices

5.3.2 Radiation Therapy Devices

5.3.3 Drug Delivery Systems

5.4 Monitoring Devices

5.4.1 Continuous Glucose Monitors (CGM)

5.4.2 Cardiac Monitoring Devices

5.4.3 Remote Patient Monitoring Systems

5.4.4 Wearable Health Devices

5.5 Surgical & Interventional Devices

5.5.1 Robotic Surgical Systems

5.5.2 Image-Guided Surgical Devices

5.5.3 Minimally Invasive Surgical Instruments

5.6 Implantable Devices

5.6.1 Cardiac Implants (Pacemakers, ICDs)

5.6.2 Orthopedic Implants

5.6.3 Neurostimulation Devices

5.6.4 Personalized/3D-Printed Implants

5.7 Other Precision Medical Devices

6. Precision Medical Devices Market, by Technology

6.1 Introduction

6.2 Artificial Intelligence & Machine Learning

6.3 Robotics & Automation

6.4 Sensor & Biosensor Technologies

6.5 Imaging Technologies

6.6 3D Printing & Additive Manufacturing

7. Precision Medical Devices Market, by Application

7.1 Introduction

7.2 Cardiology

7.3 Oncology

7.4 Neurology

7.5 Orthopedics

7.6 Diabetes Management

7.7 Respiratory Care

7.8 Others

8. Precision Medical Devices Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

8.3 Ambulatory Surgical Centers

8.4 Diagnostic Laboratories

8.5 Home Healthcare Settings

8.6 Research & Academic Institutes

9. Precision Medical Devices Market, by Precision Level (Advanced Segmentation)

9.1 Introduction

9.2 Standard Precision Devices

9.3 High-Precision Devices

9.4 Ultra-Precision / Personalized Devices

10. Precision Medical Devices Market, by Connectivity

10.1 Introduction

10.2 Standalone Devices

10.3 Connected / IoT-Enabled Devices

10.4 Cloud-Integrated Devices

11. Precision Medical Devices Market, by Geography

11.1 Introduction

11.2 North America

11.2.1 U.S.

11.2.2 Canada

11.3 Europe

11.3.1 Germany

11.3.2 U.K.

11.3.3 France

11.3.4 Italy

11.3.5 Spain

11.3.6 Netherlands

11.3.7 Sweden

11.3.8 Switzerland

11.3.9 Rest of Europe

11.4 Asia-Pacific

11.4.1 China

11.4.2 Japan

11.4.3 India

11.4.4 South Korea

11.4.5 Australia

11.4.6 Singapore

11.4.7 Thailand

11.4.8 Malaysia

11.4.9 Indonesia

11.4.10 Vietnam

11.4.11 Rest of Asia-Pacific

11.5 Latin America

11.5.1 Brazil

11.5.2 Mexico

11.5.3 Argentina

11.5.4 Chile

11.5.5 Colombia

11.5.6 Rest of Latin America

11.6 Middle East & Africa

11.6.1 UAE

11.6.2 Saudi Arabia

11.6.3 South Africa

11.6.4 Turkey

11.6.5 Israel

11.6.6 Rest of Middle East & Africa

12. Competitive Landscape

12.1 Overview

12.2 Key Growth Strategies

12.3 Competitive Benchmarking

12.4 Competitive Dashboard

12.4.1 Industry Leaders

12.4.2 Market Differentiators

12.4.3 Vanguards

12.4.4 Emerging Companies

12.5 Market Ranking/Positioning Analysis of Key Players, 2025

13. Company Profiles

Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis

13.1 Medtronic plc

13.2 Siemens Healthineers AG

13.3 GE HealthCare Technologies Inc.

13.4 Philips Healthcare

13.5 Abbott Laboratories

13.6 Boston Scientific Corporation

13.7 Stryker Corporation

13.8 Intuitive Surgical, Inc.

13.9 Johnson & Johnson (MedTech)

13.10 Becton, Dickinson and Company (BD)

13.11 Roche Diagnostics

13.12 Dexcom, Inc.

13.13 Zimmer Biomet Holdings

13.14 ResMed Inc.

13.15 Masimo Corporation

14. Appendix

14.1 Additional Customization

14.2 Related Reports

For more information about this report visit https://www.researchandmarkets.com/r/wrcjuu

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.